Leprosy, a chronic human disease with potentially debilitating neurological consequences, results from infection with Mycobacterium leprae. This unculturable pathogen has undergone extensive reductive evolution, with half of its genome now occupied by pseudogenes. Using comparative genomics, we demonstrated that all extant cases of leprosy are attributable to a single clone whose dissemination worldwide can be retraced from analysis of very rare single-nucleotide polymorphisms. The disease seems to have originated in Eastern Africa or the Near East and spread with successive human migrations. Europeans or North Africans introduced leprosy into West Africa and the Americas within the past 500 years.

Colloidal semiconductor quantum dots are fluorescent nanocrystals exhibiting exceptional optical properties, but their emission intensity strongly depends on their charging state and local environment. This leads to blinking at the single-particle level or even complete fluorescence quenching, and limits the applications of quantum dots as fluorescent particles. Here, we show that a single quantum dot encapsulated in a silica shell coated with a continuous gold nanoshell provides a system with a stable and Poissonian emission at room temperature that is preserved regardless of drastic changes in the local environment. This novel hybrid quantum dot/silica/gold structure behaves as a plasmonic resonator with a strong Purcell factor, in very good agreement with simulations. The gold nanoshell also acts as a shield that protects the quantum dot fluorescence and enhances its resistance to high-power photoexcitation or high-energy electron beams. This plasmonic fluorescent resonator opens the way to a new family of plasmonic nanoemitters with robust optical properties.

No abstract

Semiconductor heterostructure nanocrystals, especially with core/shell architectures, are important for numerous applications. Here we show that by decreasing the shell growth rate the morphology of ZnS shells on ZnSe quantum rods can be tuned from flat to islands-like, which decreases the interfacial strain energy. Further reduced growth speed, approaching the thermodynamic limit, leads to coherent shell growth forming unique helical-shell morphology. This reveals a template-free mechanism for induced chirality at the nanoscale. The helical morphology minimizes the sum of the strain and surface energy and maintains band gap emission due to its coherent core/shell interface without traps, unlike the other morphologies. Reaching the thermodynamic controlled growth regime for colloidal semiconductor core/shell nanocrystals thus offers morphologies with clear impact on their applicative potential.

Mice that had been inoculated intravenously with 6.30 log1, Mycobacterium tuberculosis H37Rv 14 days earlier were administered one of three combinations of drugs, i.e., isoniazid (INH)-rifampin (RMP)-pyrazinamide (PZA), INH-RMP, and RMP-PZA, during an initial 2-month period to mimic the initial phase of chemotherapy for human tuberculosis and during a later 4-month period to mimic the continuation phase of chemotherapy. At the end of the initial phase, all three combined regimens were found to have been highly effective in terms of the number of CFUs in the spleens of infected mice. The bactericidal activities of INH-RMP-PZA and INH-RMP were similar, whereas that of RMP-PZA was significantly greater. The spleens of all of the mice that had been treated initially with INH-RMP-PZA were culture negative by the end of 6 months of treatment, regardless of the regimen employed during the continuation phase. However, after an additional period of 6 months without treatment, the proportion of spleen culture positivity, or relapse rate, was significantly smaller in the subgroup treated with RMP-PZA during the continuation phase than in the subgroups treated with INH-RMP-PZA or INH-RMP; the relapse rate did not differ significantly between the latter two subgroups. These results suggest that antagonism occurs between INH and the combination RMP-PZA during both the initial and continuation phases of chemotherapy, compromising the benefit conferred by the addition of PZA to the combined regimen. The preliminary pharmacokinetic analysis suggested that the pharmacological interaction between INH and RMP was very likely to be involved in the mechanism of antagonism, as concomitant treatment with INH had significantly reduced the peak serum level and the area under the serum concentration-time curve of RMP in mice.At present, the duration of short-course chemotherapy for tuberculosis may be as brief as 6 months. During an initial intensive phase of 2 months, patients are treated with daily isoniazid (INH), rifampin (RMP), and pyrazinamide (PZA), with or without ethambutol or streptomycin; then they are treated with daily or twice-weekly INH-RMP during a continuation phase of 4 months (6). Without the use of PZA in the initial phase, the relapse rate is unacceptable, therefore RMP and PZA appear to be obligate components of the initial phase of the 6-month regimen (6). However, it was reported that PZA did not enhance the therapeutic activity of the combination INH-RMP in humans during the continuation phase (2).Our previous experiments on short-course preventive chemotherapy for tuberculosis in mice demonstrated that the sterilizing activity of RMP was significantly enhanced by the addition of PZA, and 2 months of treatment with the combination RMP-PZA was significantly more effective in terms of sterilizing organs and preventing subsequent disease than treatment with INH for 6 months (11). A surprising finding was that the combination RMP-PZA was more effective than the combination INH-RMP-PZA, suggesting antagonism between IN...

Epitaxial growth of a protective semiconductor shell on a colloidal quantum dot (QD) core is the key strategy for achieving high fluorescence quantum efficiency and essential stability for optoelectronic applications and biotagging with emissive QDs. Herein we investigate the effect of shell growth rate on the structure and optical properties in blue-emitting ZnSe/ZnS QDs with narrow emission line width. Tuning the precursor reactivity modifies the growth mode of ZnS shells on ZnSe cores transforming from kinetic (fast) to thermodynamic (slow) growth regimes. In the thermodynamic growth regime, enhanced fluorescence quantum yields and reduced on–off blinking are achieved. This high performance is ascribed to the effective avoidance of traps at the interface between the core and the shell, which are detrimental to the emission properties. Our study points to a general strategy to obtain high-quality core/shell QDs with enhanced optical properties through controlled reactivity yielding shell growth in the thermodynamic limit.

Mycobacterium ulcerans infection is responsible for severe skin lesions in sub-Saharan Africa. We enrolled 30 Beninese patients with Buruli ulcers in a pilot study to evaluate efficacy of an oral chemotherapy using rifampicin plus clarithromycin during an 8-week period. The treatment was well tolerated, and all patients were healed by 12 months after initiation of therapy without relapse.

Blue-emitting heavy-metal free QDs simultaneously exhibiting photoluminescence quantum yield close to unity and narrow emission line widths are essential for next-generation electroluminescence displays, yet their synthesis is highly challenging. Herein, we develop the synthesis of blue-emitting QDs by growing a thin shell of ZnS on ZnSe cores with their size larger than bulk Bohr diameter. The bulk-like size of ZnSe cores enables the emission to locate in the blue region with a narrow emission width close to its intrinsic peak width. The obtained bulk-like ZnSe/ZnS core/shell QDs display high quantum yield of 95% and extremely narrow emission width of ∼9.6 nm. Moreover, the bulk-like size of ZnSe cores reduces the energy level difference between QDs and adjacent layers in LEDs and improves charge transport. The LEDs fabricated with these high-quality QDs show bright pure blue emission with an external quantum efficiency of 12.2% and a relatively long operating lifetime.